{
    "clinical_study": {
        "@rank": "31725", 
        "arm_group": [
            {
                "arm_group_label": "PKAN", 
                "description": "This group consists of individuals diagnosed with PKAN using a combination of MRI and PANK2 gene sequencing."
            }, 
            {
                "arm_group_label": "Healthy volunteers", 
                "description": "This is a control group of healthy volunteers, matched with the PKAN group for age and sex."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to learn whether blood flow in the brain is normal in people\n      with pantothenate kinase-associated neurodegeneration (PKAN).  Specifically, preliminary\n      data suggest a region of the brain called the globus pallidus (GP), a key region affected by\n      PKAN, may have reduced blood flow. Standard MRI and perfusion scanning techniques will be\n      used to learn about cerebral blood flow in the globus pallidus and compare it to blood flow\n      in other brain regions as well as to healthy controls."
        }, 
        "brief_title": "Brain Perfusion in Pantothenate Kinase-associated Neurodegeneration (PKAN)", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Pantothenate Kinase-associated Neurodegeneration (PKAN)", 
        "condition_browse": {
            "mesh_term": [
                "Pantothenate Kinase-Associated Neurodegeneration", 
                "Nerve Degeneration"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  diagnosis of PKAN confirmed by MRI and gene testing\n\n          -  able to undergo MRI for approximately 1 hour without sedation\n\n        Exclusion Criteria:\n\n          -  deep brain stimulators or other conditions that warrant avoidance of a strong\n             magnetic field\n\n          -  previous reaction to gadolinium (Gd) contrast agent\n\n          -  acute or chronic kidney dysfunction\n\n          -  pregnant and/or nursing at time of study"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "75 Years", 
            "minimum_age": "4 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "The PKAN group consists of individuals in the United States diagnosed with PKAN."
            }
        }, 
        "enrollment": {
            "#text": "12", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 18, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01838018", 
            "org_study_id": "8777"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "PKAN", 
            "brain iron", 
            "NBIA", 
            "neurodegeneration with brain iron accumulation", 
            "Hallervorden Spatz Syndrome"
        ], 
        "lastchanged_date": "April 22, 2013", 
        "link": {
            "url": "http://www.ohsu.edu/xd/education/schools/school-of-medicine/departments/basic-science-departments/molecular-and-medical-genetics/people/primary-faculty/susan-hayflick.cfm"
        }, 
        "location": {
            "contact": {
                "email": "gregorya@ohsu.edu", 
                "last_name": "Allison M Gregory, MS", 
                "phone": "503-494-4344"
            }, 
            "facility": {
                "address": {
                    "city": "Portland", 
                    "country": "United States", 
                    "state": "Oregon", 
                    "zip": "97239"
                }, 
                "name": "Oregon Health & Science University"
            }, 
            "investigator": {
                "last_name": "Susan J Hayflick, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "2", 
        "official_title": "Brain Perfusion in Pantothenate Kinase-Associated Neurodegeneration (PKAN)", 
        "overall_contact": {
            "email": "gregorya@ohsu.edu", 
            "last_name": "Allison M Gregory, MS", 
            "phone": "503-494-4344"
        }, 
        "overall_official": {
            "affiliation": "Oregon Health and Science University", 
            "last_name": "Susan J Hayflick, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The unit of analyses will be the subject and the primary comparison will be the globus pallidus CBF between PKAN and healthy controls.", 
            "measure": "ASL-derived cerebral blood flow(CBF)", 
            "safety_issue": "No", 
            "time_frame": "Single MRI"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01838018"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Oregon Health & Science University", 
            "investigator_full_name": "Susan J. Hayflick", 
            "investigator_title": "Professor & Chair, Molecular & Medical Genetics", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "source": "Oregon Health and Science University", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Oregon Health and Science University", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Oregon Clinical and Translational Research Institute", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Susan J. Hayflick", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Observational Model: Case Control, Time Perspective: Cross-Sectional", 
        "study_type": "Observational", 
        "verification_date": "April 2013"
    }
}